Luigi A.M.J.G. van Riel
Amsterdam University Medical Centers, University of Amsterdam
Papers
2
Total Citations
38
H-Index
2
About
Luigi A.M.J.G. van Riel is a leading researcher in the field of minimally invasive prostate cancer treatment, with a primary focus on focal laser ablation (FLA) therapies. His work centers on advancing transperineal focal laser ablation (TPLA) using the innovative Soractelite™ and Echolaser® systems, aiming to reduce treatment-related morbidity while maintaining oncological efficacy. Van Riel’s major contributions include demonstrating the safety and feasibility of TPLA in a multicenter pilot study (2022, 24 citations), which showed promising short-term quality of life outcomes for patients with localized prostate cancer. He has also pioneered methods for reliable visualization of treatment effects using magnetic resonance imaging (MRI) and contrast-enhanced ultrasound (CEUS), as detailed in his 2023 study (14 citations), which established three-dimensional histological validation of ablation zones. This work addresses the critical gap in dosimetry modeling for TPLA. Van Riel’s research is notable for its translational impact, bridging novel laser technology with practical clinical application to offer patients a less invasive alternative to traditional treatments. His studies are essential reading for urologists and oncologists exploring focal therapy, with his multicenter pilot data providing foundational evidence for broader adoption of TPLA in prostate cancer management.
Research Focus
Key Achievements
Top Papers
- 1
- 2